Acetylcholine-mediated vasodilatation and tissue-type plasminogen activator release in normal and hypertensive men

Angiology

Volumn 50, Issue 4, 1999, Pages 273-282

  Dell'Omo, Giulia ^a   Ferrini, Laura ^a   Morale, Marco ^a   De Negri, Ferdinando ^a   Melillo, Elio ^a   Carmassi, Franco ^a   Pedrinelli, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOREARM BLOOD FLOW; HUMAN; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PLETHYSMOGRAPHY; SHEAR STRESS; VASODILATATION;

EID: 0033005536     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979905000402     Document Type: Article

References (35)

1. Kooistra T, Schrauwen Y, Arts J, et al: Regulation of endothelial cell t-PA synthesis and release. Int J Hematol 59:233-255, 1994.
2. Smith D, Gilbert M, Owen WG: Tissue plasminogen activator release in vivo in response to vasoactive agents. Blood 66:835-839, 1985.
3. Lambert TL, Kent TS, Whorton AR: Bradykinin stimulation of inositol polyphosphate production in porcine aortic endothelial cells. J Biol Chem 261:15288-15293, 1986.
4. 2+ mobilization in human umbilical-vein endothelial cells stimulated by thrombin and histamine. Biochem J 256:371-376, 1988.
5. Tranquille N, Emeis JJ: On the role of calcium in the acute release of tissue-type plasminogen activator and von Willebrand factor from the rat perfused hindleg region. Thromb Haemost 66:479-483, 1991.
6. Furchgott RF: Role of endothelium in response of vascular smooth muscle. Circ Res 53:557-573, 1983.
7. Tranquille N, Emeis JJ: The role of cyclic nucleotides in the release of tissue-type plasminogen activator and von Willebrand factor. Thromb Haemost 69:259-261, 1993.
8. Rydholm H, Bostrom S, Eriksson E, et al: Complex intracellular signal transduction regulates tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type-1 (PAI-1) synthesis in cultured human umbilical vein endothelium. Scand J Clin Lab Invest 55:323-330, 1995.
9. Jern S, Selin L, Bergbrant A, et al: Release of tissue type plasminogen activator in response to muscarinic receptor stimulation in human forearm. Thromb Haemost 72:588-594, 1994.
10. Wall U, Jern C, Jern S: High capacity for tissue-type plasminogen activator release from vascular endothelium in vivo. J Hypertension 15:1640-1648, 1997.
11. Jern S, Wall U, Bergbrant A, et al: Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension. Arterioscler Thromb Vasc Biol 17:3376-3383, 1997.
12. Wall U, Jern S, Tengborn L, et al: Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm. Blood 91:529-537, 1998.
13. Newby DE, Wright RA, Ludlam CA, et al: An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium. Thromb Haemost 78:1242-1248, 1997.
14. Panza JA, Quyyumi AA, Brush JE, et al: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323:22-27, 1990.
15. Linder L, Kiowski W, Buhler FR, et al: Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 81:1762-1767, 1990.
16. Nakajima K: A possible mechanism of vasoactive agents on plasminogen activator release in isolated perfused pig ears. Thromb Res 29:187-196, 1983.
17. Bashkov GV, Sergeev I, Medvedeva NA: Role of sympathetic cholinergic pathway in the neurogenous control of tissue-type plasminogen activator release into the blood. Blood Coagul Fibrinolysis 4:993-998, 1993.
18. Bohme E, Graf H, Schultz G: Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP-formation in smooth muscle and platelets. Adv Cyclic Nucleotide Res :131-143, 1978.
19. Pedrinelli R, Panarace G, Spessot M, et al: Low dose atrial natriuretic factor in primary aldosteronism: Renal, hemodynamic and vascular effects. Hypertension 14:156-163, 1989.
20. Natali A, Buzzigoli G, Taddei S, et al: Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes 39:490-500, 1990.
21. Carmassi F, Morale M, Puccetti R, et al: Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res 67:643-654, 1992.
22. Diamond SL, Eskin SG, McIntire LV: Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science 243:1483-1485, 1989.
23. Diamond SL, Sharefkin JB, Dieffenbach C, et al: Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress. J Cell Physiol 143:364-371, 1990.
24. Jern S, Selin-Sjogren L, Gan L-m, et al: Effects of shear stress on transcriptional control in vascular endothelium studied by a novel vascular perfusion system. Thromb Hemost (suppl):10, 1997.
25. Jern C, Selin L, Jern S: In-vivo release of tissue-type plasminogen activator across the human fore-arm during mental stress. Thromb Haemost 72:285-291, 1994.
26. Wall U: Association between a tissue-type plasminogen activator (t-PA) gene polymorphism and forearm vascular release rate of t-PA in: In vivo studies on local release of tissue-type plasminogen activator from vascular endothelium. PhD Thesis, University of Göteborg, Tryckt & Bunden, Vasastadens Bokbinderi AB, 1997, chapter VI.
27. Gough SCL, Smyllie J, Sheldon T, et al: The anatomical distribution of plasma fibrinolytic in man during cardiac catheterisation. Thromb Haemost 68:442-447, 1992.
28. Gerhard M, Roddy MA, Creager SJ, et al: Aging progressively impairs endothelium-dependent vasodilatation in forearm resistance vessels of humans. Hypertension 27:849-853, 1996.
29. Nitenberg A, Antony I, Foult JM: Acethylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. Am J Med 95:71-77, 1993.
30. Kelm M, Preik M, Hafner DJ, et al: Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction. Hypertension 27(part I): 346-353, 1996.
31. Preik M, Kelm M, Feelisch M, et al: Impaired effectiveness of nitric oxide-donors in resistance arteries of patients with arterial hypertension. J Hypertension 14:903-908, 1996.
32. Wall U, Jern C, Bergbrant A, et al: Enhanced levels of tissue-type plasminogen activator in borderline hypertension. Hypertension 26:796-800, 1995.
33. Eliasson M, Jansson JH, Nilsson P, et al: Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden. J Hypertension 15:349:356, 1997.
34. Genest J Jr, Cohn JS: Clustering of cardiovascular risk factors: Targeting high-risk individuals. Am J Cardiol 76:8A-20A, 1995.
35. Jern C, Erikkson E, Tengborn L, et al: Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 62:767-771, 1989.